| (Values in U.S. Thousands) | Dec, 2022 | Dec, 2021 | Dec, 2020 | Dec, 2019 | Dec, 2018 |
| Sales | 450 | 1,610 | 2,150 | 8,350 | 820 |
| Sales Growth | -72.05% | -25.12% | -74.25% | +918.29% | +290.48% |
| Net Income | -10,300 | -4,800 | -6,460 | -29,810 | -4,910 |
| Net Income Growth | -114.58% | +25.70% | +78.33% | -507.13% | +23.99% |
Innoveren Scientific Inc (IVRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
INNOVEREN SCI is a medical biosciences company which provide cellular therapeutics for the treatment of chronic health conditions. INNOVEREN SCI, formerly known as H-CYTE Inc., is based in TAMPA, Fla.
Fiscal Year End Date: 12/31